Abstract:Inflammatory bowel disease (IBD) is a chronic intestinal disease associated with the inflammatory gastrointestinal tract and microbiome dysbiosis. Probiotics are a promising intervention, and several probiotics have been reported to positively affect IBD remission and prevention, particularly on ulcerative colitis (UC). However, there is still a limitation in the knowledge of effectiveness and safety of probiotics therapies for IBD. Exploring more potential probiotics helps to find extensive evidence for probiotic intervention. This study established a rapid method for probiotics candidate screening and finally screened out one strain with the best protective effect. Forty strains isolated from four different sources were used for this screening. Hemolysis tests and acute toxic test evaluated strain safety. Zebrafish were first treated with dextran sodium sulfate (DSS) for colitis induction, and every bacteria were individually added to the fish water subsequently. Results showed eight strains could lower the larvae mortality within 3 days under a 0.6% DSS concentration, including Lacticaseibacillus rhamnosus GG, L. rhamnosus NBRC3425, Bacillus smithii DSM4216, B. smithii XY1, Bacillus coagulans NBRC12583, Bacillus coagulans XY2, Lactobacillus parafarraginis XYRR2, and Bacillus licheniformis XYT3. Among eight, B. smithii XY1 was the only strain having the equal ability to alleviate neutrophil infiltration in the larvae intestine with that ability of prednisolone under a 0.5% DSS concentration. Bacillus smithii XY1 restored intestinal epithelial cell integrity after DSS damage, as well as regulated the gene expression inflammation-related factors, indicating its bio-function of inflammatory response alleviation.

Prebiotics-Controlled Disposable Engineered Bacteria for Intestinal Diseases

Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice

A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus Smithii XY1

Engineering Diagnostic and Therapeutic Gut Bacteria

Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases

Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases

Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.

Functional modification of gut bacteria for disease diagnosis and treatment

Engineered calprotectin-sensing probiotics for IBD surveillance in humans

Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis

Self-adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery

[Construction and characterization of a bio-detector for inflammatory bowel disease]

Engineering probiotics as living diagnostics and therapeutics for improving human health

Diagnostic and Therapeutic Microbial Circuit with Application to Intestinal Inflammation

Upconversion optogenetic micro-nanosystem optically controls the secretion of light-responsive bacteria for systemic immunity regulation

Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered S. boulardii

Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced in Situ Colonization and Immunoregulation of Colitis.

Probiotic acoustic biosensors for noninvasive imaging of gut inflammation

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

Luminescent ingestible electronic capsules for in vivo regulation of optogenetic engineered bacteria

Engineered Live Biotherapeutics: Progress and Challenges